Skip to content
Qvanteq
  • Home
  • Technology
    • Key benefits
    • Mechanism of Action
    • Publications
  • Products & Services
    • Neurovascular
    • Peripheral
    • Coronary
    • Other Devices
    • Consulting
  • About us
    • Management
    • Board of Directors
    • Quality system
    • Investors
  • News & Media
    • 2020
    • 2019
    • Archive
  • Contact
Qvanteq

Category: 2012

2012

CTI Start-Up Label

Posted on 19. June 20127. February 2018

Qvanteq AG was awarded with the “CTI Start-Up Label”  in June 2012.

2012

zkb pionierpreis technopark 2012 finalist

Posted on 3. April 20127. February 2018

Qvanteq was among the finalists of the Pionierpreis 2012. 15 companies have been nominated.

2012

Qvanteq in “20minuten”: “Weniger Herzinfarkte dank neuer Stent-Technologie”

Posted on 13. January 20127. February 2018

A portrait of Qvanteq AG was published in the the Swiss  journal “20minuten” under the the title “Weniger Herzinfarkte dank neuer Stent-Technologie”.   Full article (g).

Recent News

  • Stop the activation of the blood coagulation cascade by your medical device
  • Make any surface antithrombotic
  • Qvanteq is using MedtechVault
  • In-vitro thrombogenicity screening capacity
  • Qvanteq has moved to new offices

Qvanteq AG

Technoparkstr. 1, 8005 Zürich, Switzerland
+41 44 500 98 90
info@qvanteq.com

More

  • Meet us
  • Subscribe
  • Contact
  • Disclaimer
Copyright Qvanteq AG